Today we have the CEO of Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF) Mr. Christopher Moreau sitting down with us for an exclusive interview regarding the company’s operations surrounding Covid-19.EI) Mr. Moreau, for investors that are not very familiar with Algernon Pharmaceuticals, could you tell us the vision of Algernon and how it all began?
click below to view the articles
